G.O.N. Oosterhof

3.7k total citations
62 papers, 2.5k citations indexed

About

G.O.N. Oosterhof is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, G.O.N. Oosterhof has authored 62 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in G.O.N. Oosterhof's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (13 papers) and Bladder and Urothelial Cancer Treatments (11 papers). G.O.N. Oosterhof is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (13 papers) and Bladder and Urothelial Cancer Treatments (11 papers). G.O.N. Oosterhof collaborates with scholars based in Netherlands, United States and Denmark. G.O.N. Oosterhof's co-authors include Jelle O. Barentsz, G.J. Jager, Jack A. Schalken, F.M.J. Debruyne, J. Alfred Witjes, E T Ruijter, Herbert F.M. Karthaus, Jean J. de la Rosette, H. Ewout Schaafsma and F M Debruyne and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and The Journal of Urology.

In The Last Decade

G.O.N. Oosterhof

62 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.O.N. Oosterhof Netherlands 25 1.3k 824 592 543 299 62 2.5k
Koji Okihara Japan 24 1.3k 1.0× 310 0.4× 499 0.8× 330 0.6× 266 0.9× 132 2.0k
Srinivas Vourganti United States 26 1.9k 1.5× 535 0.6× 525 0.9× 479 0.9× 291 1.0× 92 2.6k
Joan Sweet Canada 34 1.9k 1.4× 364 0.4× 1.0k 1.7× 1.0k 1.9× 371 1.2× 108 3.3k
Vincent J. Gnanapragasam United Kingdom 37 2.4k 1.8× 843 1.0× 956 1.6× 429 0.8× 472 1.6× 143 3.6k
Kentaro Kuroiwa Japan 38 2.9k 2.2× 1.1k 1.4× 790 1.3× 765 1.4× 468 1.6× 100 4.1k
I.D. Kaplan United States 17 1.5k 1.2× 255 0.3× 657 1.1× 361 0.7× 449 1.5× 47 2.4k
Erik B. Cornel Netherlands 25 2.5k 1.9× 503 0.6× 651 1.1× 688 1.3× 259 0.9× 68 3.5k
Elisabeth Kjellén Sweden 28 1.5k 1.1× 909 1.1× 473 0.8× 461 0.8× 676 2.3× 120 3.1k
Andres Jan Schrader Germany 34 2.0k 1.5× 551 0.7× 1.1k 1.9× 707 1.3× 1.2k 4.0× 162 3.8k
Reiji Haba Japan 31 1.2k 0.9× 529 0.6× 692 1.2× 880 1.6× 1.1k 3.8× 216 3.5k

Countries citing papers authored by G.O.N. Oosterhof

Since Specialization
Citations

This map shows the geographic impact of G.O.N. Oosterhof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.O.N. Oosterhof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.O.N. Oosterhof more than expected).

Fields of papers citing papers by G.O.N. Oosterhof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.O.N. Oosterhof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.O.N. Oosterhof. The network helps show where G.O.N. Oosterhof may publish in the future.

Co-authorship network of co-authors of G.O.N. Oosterhof

This figure shows the co-authorship network connecting the top 25 collaborators of G.O.N. Oosterhof. A scholar is included among the top collaborators of G.O.N. Oosterhof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.O.N. Oosterhof. G.O.N. Oosterhof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Barentsz, Jelle O., et al.. (1998). Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.. Radiology. 207(3). 791–797. 85 indexed citations
3.
Meuleman, E.J.H., et al.. (1997). Urological Complications in Renal Transplantation. European Urology. 31(4). 433–435. 34 indexed citations
4.
Steffens, Martijn G., Otto C. Boerman, Jeannette Oosterwijk‐Wakka, et al.. (1997). Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.. Journal of Clinical Oncology. 15(4). 1529–1537. 124 indexed citations
5.
Tjan‐Heijnen, Vivianne C. G., G.O.N. Oosterhof, Ronald de Wit, & P.H.M. de Mulder. (1997). Treatment in germ cell tumours: state of the art. European Journal of Surgical Oncology. 23(2). 110–117. 10 indexed citations
6.
Witjes, Wim P.J., J.A. Witjes, G.O.N. Oosterhof, & F.M.J. Debruyne. (1996). Update on the Dutch Cooperative Trial: Mitomycin versus Bacillus calemtte Guerin Tice versus Bacillus Calmette Guerin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Radboud Repository (Radboud University). 14. 10–16. 1 indexed citations
7.
Bierkens, A.F., G.O.N. Oosterhof, E J Meuleman, & F.M.J. Debruyne. (1996). Anterograde PercutaneousTreatment of UreterointestinalStrictures following. European Urology. 30(3). 363–368. 24 indexed citations
8.
Jager, G.J., et al.. (1996). Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.. American Journal of Roentgenology. 167(6). 1503–1507. 184 indexed citations
9.
Jager, G.J., E T Ruijter, C A van de Kaa, et al.. (1996). Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology.. American Journal of Roentgenology. 166(4). 845–852. 194 indexed citations
10.
Mulder, PHM de, G.O.N. Oosterhof, C Bouffioux, et al.. (1995). EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. British Journal of Cancer. 71(2). 371–375. 46 indexed citations
11.
Barentsz, Jelle O., et al.. (1995). Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences.. American Journal of Roentgenology. 164(1). 109–115. 41 indexed citations
12.
Cornel, Erik B., G. Smits, J.E. de Ruijter, et al.. (1995). In vitro proton magnetic resonance spectroscopy of four human prostate cancer cell lines. The Prostate. 26(5). 275–280. 16 indexed citations
13.
Witjes, Wim P.J., et al.. (1995). Prostate‐specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis. British Journal of Urology. 76(1). 47–53. 50 indexed citations
14.
Mulders, Peter F.A., et al.. (1994). Prognostic factors in pT a ‐pT 1 superficial bladder tumours treated with intravesical instillations. British Journal of Urology. 73(4). 403–408. 51 indexed citations
15.
16.
Oosterhof, G.O.N., et al.. (1993). Nerve‐sparing Retroperitoneal Lymphadenectomy for Low Stage Testicular Cancer. British Journal of Urology. 71(3). 336–339. 11 indexed citations
17.
Witjes, Wim P.J., Simon Horenblas, G.O.N. Oosterhof, H. Ewout Schaafsma, & F M Debruyne. (1993). Neoadjuvant Therapy inProstate Cancer - Is It of AnyUse?. European Urology. 24(4). 433–437. 3 indexed citations
18.
Mulders, Peter F.A., et al.. (1992). Value of Biochemical Markers in the Management of Disseminated Prostatic Cancer. European Urology. 21(1). 2–5. 23 indexed citations
19.
Oosterhof, G.O.N., A. J. Hoitsma, J. Alfred Witjes, & F.M.J. Debruyne. (1992). Diagnosis and Treatment of Urological Complications in Kidney Transplantation. Urologia Internationalis. 49(2). 99–103. 26 indexed citations
20.
Oosterhof, G.O.N., et al.. (1988). Kidney transplantation in patients with a urinary diversion. World Journal of Urology. 6(2). 91–94. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Okihara Breakdown of academic impact, for papers by Srinivas Vourganti Breakdown of academic impact, for papers by Joan Sweet Breakdown of academic impact, for papers by Vincent J. Gnanapragasam Breakdown of academic impact, for papers by Kentaro Kuroiwa Breakdown of academic impact, for papers by I.D. Kaplan Breakdown of academic impact, for papers by Erik B. Cornel Breakdown of academic impact, for papers by Elisabeth Kjellén Breakdown of academic impact, for papers by Andres Jan Schrader Breakdown of academic impact, for papers by Reiji Haba
Rankless by CCL
2026